Clinical Trial: Biological Effects of Quercetin in COPD Phase II
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Chronic Obstructive Pulmonary Disease
Study Type: INTERVENTIONAL
Official Title: Effects of Quercetin on the Oxidative Stress and Inflammatory Markers in COPD Phase II
Brief Summary:
This study determines whether quercetin supplementation reduces the inflammation and oxidative stress markers in patients with chronic obstructive pulmonary disease.It is small study with 8 subjects receiving quercetin 1000 mg/day, 8 patients receiving 500 mg/day and 4 subjects receive placebo.
Read more